Skip to content
sellNotable cluster of 3

Christine Fox sold $753k of TEVA

EVP, Head of U.S. Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD. 30,000 shares at an average of $25.11, traded Nov 14, 2025, filed Nov 18, 2025.

Warning score
72
Value
$753k
30,000 shares
Holdings after
28,384
-51% from before
From 52-week low
+98%
low $12.82, close $25.41
From 52-week high
-2%
high $25.83, as of Nov 14, 2025

Score components

  • Role
    Officer
    +15
  • Trade size
    $753k at market
    +22
  • Share of holdings sold
    Sold 51% of holdings
    +20
  • Cluster
    3 insiders selling within 14 days
    +15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +22.1%, 3m +38.5%, 6m +37.2%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

TEVAOct 9, 2026 · close 41.10
Since filing Nov 18, 2025: +65.5%SPY +19.2% · excess +46.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001193125-25-286134, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Nov 14, 2025SOpen-market sale
Ordinary Shares
-30,000$25.11$753k28,384Nov 18, 2025

Related signals

Other insiders at TEVA PHARMACEUTICAL INDUSTRIES LTD and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
68Notable
TEVAsell 2
TEVA PHARMACEUTICAL INDUSTRIES LTD
Roberto Mignone
director
$14M
367,600 shares
-100%
32Weak
TEVAsell 2
TEVA PHARMACEUTICAL INDUSTRIES LTD
Brian Savage
Interim Chief Legal Officer
$285k
7,342 shares
-46%
30Weak
TEVAsell 3
TEVA PHARMACEUTICAL INDUSTRIES LTD
Ronit Satchi-Fainaro
director
$15k
415 shares
-0%
40Moderate
TEVAsell 3
TEVA PHARMACEUTICAL INDUSTRIES LTD
Amir Weiss
Chief Accounting Officer
$355k
9,445 shares
-47%
41Moderate
TEVAsell 610b5-1
TEVA PHARMACEUTICAL INDUSTRIES LTD
Evan Lippman
EVP, Business Development
$680k
18,600 shares
-42%
30Weak
TEVAsell 4
TEVA PHARMACEUTICAL INDUSTRIES LTD
Tal Zvi Zaks
director
$593
17 shares
-0%
23Weak
TEVAsell 410b5-1
TEVA PHARMACEUTICAL INDUSTRIES LTD
Eric A Hughes
See "Remarks"
$892k
25,578 shares
-16%
32Weak
TEVAsell 410b5-1
TEVA PHARMACEUTICAL INDUSTRIES LTD
Placid Jover
See "Remarks"
$447k
12,827 shares
-65%
64Notable
TEVAsell 3
TEVA PHARMACEUTICAL INDUSTRIES LTD
Matthew Shields
EVP, Global Operations
$322k
9,989 shares
-100%
62Notable
TEVAsell 310b5-1
TEVA PHARMACEUTICAL INDUSTRIES LTD
Eliyahu Sharon Kalif
EVP, Chief Financial Officer
$3.6M
106,563 shares
-62%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.